Table 1.
Cases (%)(n = 46) | Controls (%)(n = 184) | p-value | |
---|---|---|---|
Age (median, range) | 62 (range 20-83) | 58 (range 21-77) | 0.43 |
Gender | 0.17 | ||
Male | 26 (56.5) | 125 (67.9) | |
Female | 20 (43.5) | 59 (32.1) | |
Neutropenia | 35 (76.1) | 40 (21.7) | <0.0001 |
Use of steroids | 18 (39.1) | 15 (8.2) | <0.0001 |
Previous allogeneic HCT | 15 (32.6) | 27 (14.7) | 0.0093 |
GvHD | 6 (13.0) | 8 (4.3) | 0.039 |
T-lymphocyte inhibitor | 12 (26.1) | 69 (37.5) | 0.17 |
Hemodialysis | 1 (2.2) | 3 (1.6) | 1 |
Diabetes | 1 (2.2) | 12 (6.5) | 0.47 |
HCT, hematopoietic cell transplantation; GvHD, graft-versus-host disease.
p-values <0.05 in bold (denote statistical significance).